Arcus Biosciences, Inc. (RCUS) › Shareholders' EquityArcus Biosciences, Inc. (RCUS) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: -$2.17M2016: -$19.99M2017: -$72.33M2018: $234.94M2019: $164.00M2020: $502.00M2021: $842.00M2022: $657.00M2023: $462.00M2024: $485.00M2025: $631.00M$631.00M2015Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$631.00M+30.1%2024$485.00M+5.0%2023$462.00M-29.7%2022$657.00M-22.0%2021$842.00M+67.7%2020$502.00M+206.1%2019$164.00M-30.2%2018$234.94M+424.8%2017-$72.33M-261.7%2016-$19.99M-821.0%2015-$2.17M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share